Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000647854 | SCV000769657 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2023-05-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358851 | SCV002652574 | uncertain significance | Inborn genetic diseases | 2020-06-15 | criteria provided, single submitter | clinical testing | The p.N1967S variant (also known as c.5900A>G), located in coding exon 19 of the WNK1 gene, results from an A to G substitution at nucleotide position 5900. The asparagine at codon 1967 is replaced by serine, an amino acid with highly similar properties. This amino acid position is not conserved, however, Serine is a reference amino acid in several species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000647854 | SCV002790243 | uncertain significance | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2021-11-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003420135 | SCV004116230 | uncertain significance | WNK1-related disorder | 2022-11-21 | criteria provided, single submitter | clinical testing | The WNK1 c.5144A>G variant is predicted to result in the amino acid substitution p.Asn1715Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.026% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-995114-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |